Evidence method
Level · gp.fundamentals.debt_to_revenue
274.26% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
XERS · Jun 30, 2026
Xeris Biopharma Holdings, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001867096-26-000065General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
8.97% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
28.74% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
87.87% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.operating_margin
5.62% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.58% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
12.02% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History5 statesHistory building
Period transition
What moved in the state?
- Previous
- 266.13%
- Current
- 274.26%
- Delta
- 8.13%
- Previous
- 11.87%
- Current
- 8.97%
- Delta
- -2.90%
- Previous
- 38.27%
- Current
- 28.74%
- Delta
- -9.53%
- Previous
- 89.30%
- Current
- 87.87%
- Delta
- -1.43%
- Previous
- 9.52%
- Current
- 5.62%
- Delta
- -3.91%
- Previous
- 10.57%
- Current
- 11.58%
- Delta
- 1.02%
- Previous
- 4.98%
- Current
- 12.02%
- Delta
- 7.03%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Xeris Biopharma Holdings, Inc. →Transitioned To · XERS Fundamental State →Transitioned To · XERS BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · XERS CASH_GENERATION_DECREASED →Transitioned To · XERS GROWTH_DECREASED →Transitioned To · XERS INVENTORY_PRESSURE_DECREASED →Transitioned To · XERS PROFITABILITY_DECREASED →Transitioned To · XERS R_AND_D_INTENSITY_INCREASED →Transitioned To · XERS SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.